CS18: a new drug that can potentially overcome cancer drug resistance
August 05, 2026
August 05, 2026
HOUSTON, Texas, Aug. 5 -- The Baylor College of Medicine posted the following news:
* * *
CS18: a new drug that can potentially overcome cancer drug resistance
*
Researchers at Baylor College of Medicine have developed a drug called CS18 that disrupts the ability of cancer cells to survive therapy. The findings, published in Science Advances, support exploring the possibility of using CS18 to treat human cancer in the future.
" . . .
* * *
CS18: a new drug that can potentially overcome cancer drug resistance
*
Researchers at Baylor College of Medicine have developed a drug called CS18 that disrupts the ability of cancer cells to survive therapy. The findings, published in Science Advances, support exploring the possibility of using CS18 to treat human cancer in the future.
" . . .